Tuscaloosa, ALABAMA1 Active Studies

Substance Use Disorder Clinical Trials in Tuscaloosa, ALABAMA

Find 1 actively recruiting substance use disorder clinical trials in Tuscaloosa, ALABAMA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
952
Enrolling

Recruiting Substance Use Disorder Studies in Tuscaloosa

About Substance Use Disorder Clinical Trials in Tuscaloosa

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 1 substance use disorder clinical trials recruiting participants in Tuscaloosa, ALABAMA. These studies are seeking a combined 952 participants. Research is being sponsored by VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Tuscaloosa — FAQ

Are there substance use disorder clinical trials in Tuscaloosa?

Yes, there are 1 substance use disorder clinical trials currently recruiting in Tuscaloosa, ALABAMA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tuscaloosa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tuscaloosa research site will contact you about next steps.

Are clinical trials in Tuscaloosa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tuscaloosa studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 1 active trials in Tuscaloosa are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated March 2, 2026 from ClinicalTrials.gov